KR930019217A - Tumor treatment - Google Patents

Tumor treatment Download PDF

Info

Publication number
KR930019217A
KR930019217A KR1019920004390A KR920004390A KR930019217A KR 930019217 A KR930019217 A KR 930019217A KR 1019920004390 A KR1019920004390 A KR 1019920004390A KR 920004390 A KR920004390 A KR 920004390A KR 930019217 A KR930019217 A KR 930019217A
Authority
KR
South Korea
Prior art keywords
isoguanosine
therapeutic agent
tumor therapeutic
tumor treatment
protoberberine
Prior art date
Application number
KR1019920004390A
Other languages
Korean (ko)
Other versions
KR100204308B1 (en
Inventor
한영복
경홍기
문정조
김춘원
김종배
김정한
Original Assignee
김영길
주식회사 녹십자
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김영길, 주식회사 녹십자 filed Critical 김영길
Priority to KR1019920004390A priority Critical patent/KR100204308B1/en
Publication of KR930019217A publication Critical patent/KR930019217A/en
Application granted granted Critical
Publication of KR100204308B1 publication Critical patent/KR100204308B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Abstract

본 발명은 이소구아노신과 프로토베르베린 알카로이드를 유효성분으로 혼합함을 특징으로 하는 종양치료제에 관한 것이다.The present invention relates to a tumor therapeutic agent comprising isoguanosine and protoberberine alkaloid as an active ingredient.

Description

종양 치료제Tumor treatment

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

제1도는 발명 조성물의 항종양 유효 스펙트럼을 나타낸다.1 shows the anti-tumor effective spectrum of the inventive composition.

Claims (3)

이소구아노신과 프로토베르베린 알카로이드를 유효성분으로 혼합함을 특징으로 하는 종양치료제.A tumor therapeutic agent, characterized by mixing isoguanosine and protoberberine alkaloids as an active ingredient. 제1항에 있어서, 이소구아노신 및 프로토베르베린 알카로이드와 약학적 불활성 성분을 함유하는 종양치료제.The tumor therapeutic agent according to claim 1, which comprises isoguanosine and protoberberine alkaloid and a pharmaceutically inactive ingredient. 제1항에 있어서, 이소구아노신과 프로토베르베린 알카로이드의 조성비율이 8:1 내지 11:1인 종양치료제.The tumor therapeutic agent according to claim 1, wherein the composition ratio of isoguanosine and protoberberine alkaloid is 8: 1 to 11: 1. ※참고사항 : 최초출원 내용에 의하여 공개되는 것임.※ Note: This is to be disclosed by the original application.
KR1019920004390A 1992-03-18 1992-03-18 Anticancer drug KR100204308B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920004390A KR100204308B1 (en) 1992-03-18 1992-03-18 Anticancer drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920004390A KR100204308B1 (en) 1992-03-18 1992-03-18 Anticancer drug

Publications (2)

Publication Number Publication Date
KR930019217A true KR930019217A (en) 1993-10-18
KR100204308B1 KR100204308B1 (en) 1999-06-15

Family

ID=19330510

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920004390A KR100204308B1 (en) 1992-03-18 1992-03-18 Anticancer drug

Country Status (1)

Country Link
KR (1) KR100204308B1 (en)

Also Published As

Publication number Publication date
KR100204308B1 (en) 1999-06-15

Similar Documents

Publication Publication Date Title
CA2275889A1 (en) Formulation and method for treating neoplasms by inhalation
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
IE790756L (en) Cerebral therapeutic agent
NO904694L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES.
GEP20002332B (en) Cefalosporin Derivatives
NO893616L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRICYCLIC COMPOUNDS.
FR2697841B1 (en) New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
ES2108129T3 (en) NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE.
CA2202531A1 (en) Lyophilizate of lipid complex of water insoluble camptothecins
FR2697019B1 (en) New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
SE8201202L (en) ANTI-INFLAMMATORY ANALGETIC CATAPLASM
SE7613588L (en) PROCEDURE FOR PREPARATION OF 3,4-DIHYDRO-CHINAZOLINE DERIVATIVES
KR910005841A (en) Pharmacological composition acting on skin microcirculation
IT9067434A0 (en) PROCEDURE TO IMPROVE THE THERAPEUTIC EFFICACY OF LIPOSOLUBLE CORTICOSTEROIDS AND COMPOSITION FOR THE IMPLEMENTATION OF THIS PROCEDURE
NO910874D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.
MD502G2 (en) New adenozine derivatives, methods of obtainitg thereof, farmaceutical compositions on the base thereof
KR930019217A (en) Tumor treatment
NO905327L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBAMOIL OIL DERIVATIVES.
KR930019216A (en) Tumor treatment
DE59101818D1 (en) Pharmaceutical preparation containing stigmasta-4-en-3-one and their use.
FR2699920B1 (en) Imidazo [2,1-b] benzothiazole-3-acetamide derivatives, their preparation and their therapeutic use.
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
ATE74505T1 (en) PAIN REMEDY.
NO900942D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AZACYCLOOKTADIEN DERIVATIVES.
FR2697253B1 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use.

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050325

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee